The FDA can spew anything they want even after overwhelming proof and top experts in the field of this science and medicine report the opposite and hundreds of thousands to millions of deaths due to the vaccines and improperly treating cases at the onset of illness! How did they achieve such results with this when the Flu vaccine is usually not better than 50% efficacy or less after many years of it being tried and tested vaccine for decades!
“Specifically, in the FDA’s review for approval, the agency analyzed effectiveness data from approximately 20,000 vaccine and 20,000 placebo recipients ages 16 and older who did not have evidence of the COVID-19 virus infection within a week of receiving the second dose. The safety of Comirnaty was evaluated in approximately 22,000 people who received the vaccine and 22,000 people who received a placebo 16 years of age and older.
Based on results from the clinical trial, the vaccine was 91% effective in preventing COVID-19 disease.
The most commonly reported side effects by those clinical trial participants who received Comirnaty were pain, redness and swelling at the injection site, fatigue, headache, muscle or joint pain, chills, and fever. The vaccine is effective in preventing COVID-19 and potentially serious outcomes including hospitalization and death.” fda.gov/news
Pure Insanity! The LIES are CONTINUOUS and a COVER-UP is more imperative to the perpetrators as they move forward with their Agenda!
“Oh, what a tangled web we weave, when first we practice to deceive!” (Sir Walter Scott, 1808).
Brother in Christ Jesus,
Lawrence Morra III
The U.S. Food and Drug Administration should have demanded adequate, controlled studies with long-term follow up, and made data publicly available, before granting full approval to COVID-19 vaccines, says British Medical Journal Associate Editor Peter Doshi.
EDITOR’S NOTE: This analysis was published Monday before the U.S. Food and Drug Administration announced it had granted full approval to Pfizer’s COVID vaccine. The information in this piece provides insightful arguments for why the FDA should not have rushed to license Pfizer’s COVID vaccine.
On July 28, Pfizer and BioNTech posted updated results for their ongoing phase 3 COVID-19 vaccine trial. The preprint came almost a year to the day after the historical trial commenced, and nearly four months since the companies announced vaccine efficacy estimates “up to six months.”
But you won’t find 10 month follow-up data here. While the preprint is new, the results it contains…
View original post 654 more words